NCT07413523
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +15 more
- Locations
-
- IRCCS Humanitas Research Hospital Rozzano, Milan, Italy
Clinical trial condition
Urinary Bladder Neoplasms
Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.
1,199 public trials
263 recruiting studies
Urinary Bladder Neoplasms trial results
Recruiting
AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
NCT05002556
- Conditions
- Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
- Locations
-
- Hopital Prive de Provence Aix-en-Provence, France
- CHU Angers Angers, France
- Hopital Privé Arras les Bonnettes Arras, France
- Centre hospitalier Privé Montgradé Aubergenville, France
Recruiting
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
NCT05982561
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Arkansas Urology Research Center Little Rock, Arkansas, United States
- Indiana University School of Medicine Indianapolis, Indiana, United States
- Washington University St Louis, Missouri, United States
NCT02333604
- Conditions
- Adnexal Diseases, Blood Protein Disorders, Bone Marrow Diseases, +83 more
- Locations
-
- Cancer Support Community Research & Training Institute Washington D.C., District of Columbia, United States
NCT07545694
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo A. Gemelli, 100168 - Roma Rome, Italy
NCT05562791
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
NCT07322263
- Conditions
- BCG-Refractory Bladder Cancer, BCG-Unresponsive Bladder Cancer, Bladder Cancer, +25 more
- Locations
-
- University of Iowa Iowa City, Iowa, United States
NCT03193970
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- University of California - San Francisco San Francisco, California, United States
- Stanford University Stanford, California, United States
- Emory University Atlanta, Georgia, United States
- University of Chicago Chicago, Illinois, United States
NCT05483868
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Arkansas Urology Little Rock, Arkansas, United States
- Tower Urology Los Angeles, California, United States
- Saint John's Cancer Institute Santa Monica, California, United States
- Montefiore Medical Center The Bronx, New York, United States
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
NCT06567743
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, High-Risk Non-Muscle-Invasive Bladder Cancer, +9 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Arizona Urology Specialty Tucson, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Arkansas Urology Little Rock, Arkansas, United States